Ampio Pharmaceuticals Inc logo

Ampio Pharmaceuticals Inc (AMPE)

Market Closed
11 Aug, 20:00
AMEX AMEX
AMEX AMEX Primary
$
0. 18
0
0%
$
207.88K Market Cap
- P/E Ratio
- Div Yield
334 Volume
0 Eps
$ 0.18
Previous Close
Add Transaction
Day Range
0.01 0.18
Year Range
0 0.64
Want to track AMPE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free

Summary

AMPE closed yesterday higher at $0.18, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, AMPE stock gained 3,421.1538%.
AMPE is not paying dividends to its shareholders.
The last earnings report, released on Mar 25, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Ampio Pharmaceuticals Inc has completed 3 stock splits, with the recent split occurring on Sep 12, 2023.
The company's stock is traded on one exchange.

AMPE Chart

No Data

People also search for

MYO
Myomo Inc.
$ 1.51
0%
NNVC
Nanoviricides Inc.
$ 1.35
-0.3676%
NSRX
Nasus Pharma Ltd.
$ 3.24
-2.1631%
CCEL
Cryo-Cell International Inc.
$ 3.83
+9.1168%
SER
Serina Therapeutics Inc.
$ 2.8
+0.7194%

Ampio Pharmaceuticals Inc (AMPE) FAQ

What is the stock price today?

The current price is $0.18.

On which exchange is it traded?

Ampio Pharmaceuticals Inc is listed on AMEX.

What is its stock symbol?

The ticker symbol is AMPE.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 207.88K.

Has Ampio Pharmaceuticals Inc ever had a stock split?

Ampio Pharmaceuticals Inc had 3 splits and the recent split was on Sep 12, 2023.

Ampio Pharmaceuticals Inc Profile

Biotechnology Industry
Healthcare Sector
Michael A. Martino CEO
AMEX Exchange
03209T307 CUSIP
US Country
6 Employees
- Last Dividend
12 Sep 2023 Last Split
31 Mar 2010 IPO Date

Overview

Ampio Pharmaceuticals, Inc. is a biopharmaceutical entity focusing its efforts on the discovery and development of novel therapies aimed at treating common inflammatory conditions such as osteoarthritis of the knee (OAK). With its operations rooted in Englewood, Colorado, Ampio is committed to addressing the significant unmet needs in the therapeutic landscape of OAK. Through innovative research and development practices, the company strives to advance its pipeline products, targeting the debilitating pain and discomfort associated with this widespread condition.

Products and Services

  • OA-201

    A small molecule formulation specifically designed by Ampio Pharmaceuticals for the treatment of pain associated with osteoarthritis of the knee (OAK). OA-201 represents the company's flagship product, encapsulating years of dedicated research to offer an innovative, targeted solution for individuals struggling with the challenges of OAK. By focusing on this small molecule approach, Ampio aims to provide a therapeutic alternative that addresses the symptomatic pain of osteoarthritis, potentially improving the quality of life for patients.

Contact Information

Address: 9800 Mount Pyramid Court
Phone: 720 437 6500
Download app banner
Blog Affiliate Program About Terms Privacy Help Contact Us
2026 © Marketlog. All Rights Reserved.
Play store app banner Play store app banner dark App store app banner App store app banner dark